Approved for DAWNZERA is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.. Donidalorsen is an ASO-GalNAc conjugate that causes RNase H1-mediated degradation of prekallikrein (PKK) mRNA. Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS…
Loading full data from Know Your Drugs Institute…